Two more COVID-19 vaccines approved under EUA
India approved two more vaccines, Corbevax and Covovax, against COVID-19 under emergency use authorization (EUA). These vaccines got approval for administration to adults aged above 18 years. Mansukh Mandaviya, the Union Minister for Health & Family Welfare, tweeted on this matter yesterday.
Corbevax is manufactured by Hyderabad-based Biological-E. It is a protein subunit vaccine. The vaccine is co-developed by Biological E, Baylor College of Medicine in Houston, and Dynavax Technologies, USA.
Covovax is manufactured by Serum Institute of India, Pune under licence from Novavax, a US-based company. It is a nanoparticle-based vaccine.
World Health Organisation (WHO) approved Covovax under Emergency Use Listing to ensure more people across the globe get vaccinated. The vaccine is available as part of the COVAX facility.
Currently, Covishield, Covaxin and Sputnik V are used in India’s vaccination programme. There is no update on the inclusion of Corbevax and Covovax vaccines in the country’s vaccination drive.
Recently, the Food and Drugs Administration (FDA) approved Molnupiravir for the treatment of COVID-19 patients with mild and moderate symptoms. The drug showed promising results in clinical trials. Besides, the administration of the drug is easy as it can be consumed as a pill.
In this context, thirteen companies in the country get readied to manufacture the drug. This drug has been approved under EUA to treat COVID-19 patients who have a risk of progression.
The FDA, in its recent statement, said that Molnupiravir is effective in treating COVID-19. However, extra caution shall be taken while prescribing the drug. It shall be prescribed only to certain adults where it is clinically appropriate.
The drug should not be used as preventive medicine. FDA approved Paxlovid manufactured by Pfizer Inc. under EUA. However, the drug is yet to get approval in India.
Meanwhile, Cipla is planning to launch Molnupiravir under the brand name Cipmolnu.
Image by ulleo from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/photos/ampoules-vaccination-vaccine-2045833/
Recent Posts
- Jumbotail: Transforming India’s grocery supply chainJumbotail serves tens of thousands of retailers across India and continues to grow beyond its initial stronghold in Bengaluru.
- RBI’s new rules put customers first in financial products salesCustomer compensation forms another key pillar of the framework.
- Little pilot steals the spotlight at Jewar Airport launchAs commercial operations began at Noida International Airport, a young girl dressed in a pilot's uniform became the centre of attention on the inaugural flight from Chaudhary Charan Singh International Airport. Her appearance charmed fellow passengers and added a heartwarming touch to the historic occasion.
- Jumbotail: Transforming India’s grocery supply chain
What’s new at WeRIndia.com
News from 700+ sources
-
MP Sanatan Pandey Responds Firmly to Speculations About Leaving SP
-
Shikari Naya Hai, Jal Puraana Hai: Owaisi on Defections
-
Odisha approves nearly 76,612 crore-worth projects; set to create 50,517 jobs
-
How PM SHRI Scheme Became A Plank For Ideological Gymnastics In Kerala
-
Grand Celebration of International Yoga Day at GIFT City, Over 1,500 Participants Join In
-
Grand Celebration of International Yoga Day in Gujarats GIFT City
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..








Leave a Reply